Related Experiment Video
Updated: May 24, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
[A pedigree analysis of pulmonary embolism caused by compound heterozygous mutations of protein C]
1Department of Hematology, Southern Medical University, Guangzhou, China. yexu2000@yeah.net
Insights
This study identified compound heterozygous mutations in the protein C (PC) gene (PC E29K and PC R147W) in a patient with pulmonary embolism. These mutations cause type II PC deficiency, increasing thrombosis risk.
Area of Science:
- Genetics
- Molecular Biology
- Hematology
Background:
- Protein C (PC) deficiency is a genetic disorder that increases the risk of venous thromboembolism.
- Type II PC deficiency is characterized by reduced PC activity with normal PC antigen levels.
Observation:
- A patient with pulmonary embolism and his family members were investigated for the molecular basis of PC deficiency.
- Blood samples were analyzed for PC, PS, and AT activities, and PC antigen levels.
- PC gene sequencing was performed to identify mutations.
Findings:
- The proband presented with compound heterozygous mutations in the PC gene: PC E29K (novel) and PC R147W (previously reported).
- These mutations, inherited from his parents, resulted in type II PC deficiency.
- The proband's sister was a heterozygote for the PC R147W mutation.
Implications:
- The identified mutations contribute to the understanding of molecular pathogenesis in PC deficiency.
- PC E29K represents a novel mutation associated with hereditary PC deficiency.
- PC R147W is linked to type II hereditary PC deficiency and recurrent thrombosis, highlighting its clinical significance.
Objective:
To study the molecular pathogenesis of protein C (PC) deficiency in a patient with pulmonary embolism and in his family members.
Methods:
Anticoagulated blood samples were collected from the proband and his family members to detect PC, PS and AT activities. PC antigen level was measured using ELISA. The genomic DNA was extracted to amplify all the 9 exons and their flanking sequences of PC gene using PCR, and the PCR products were sequenced. The mutated exons identified were amplified and sequenced for the other family members.
Results:
The proband and his parents and sister were identified as carriers of PC gene mutation, which led to type II PC deficiency. Sequencing of the proband's PC gene showed two heterozygous point mutations in exon 3 (G5540A) and exon 7 (C10230T) to cause compound heterozygous mutations of PC E29K and PC R147W, which were inherited from his father and mother, respectively. His sister was a heterozygote of PC R147W.
Conclusion:
The proband is a compourd heterozygous mutations carrier of PC E29K and PC147W. PC E29K is a novel PC mutation, and PC R147W is a reported PC gene mutation seen in patients with type II hereditary PC deficiency and recurrent thrombosis.
Related Concept Videos
Pulmonary Embolism I: Introduction
Pulmonary Embolism I: Introduction
Pedigree Analysis
Pedigree Analysis
Cystic Fibrosis: Pathogenesis
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation, but...
Pulmonary Embolism II: Diagnostic Studies and Interprofessional Care
